Tell us about your biggest trial win from January 2016 to July 2017 and how you achieved the result for your client.

Representing Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co.) in its multibillion-dollar patent-infringement case against Gilead Sciences Inc. over sofosbuvir, the active ingredient in Gilead’s blockbuster hepatitis C drugs Sovaldi and Harvoni.